Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Open Access
Abstract
The use of nanoparticles as drug carriers in oncology has evolved from their traditional role as chemotherapy carriers to their application in immunotherapy, exploiting not only their passive accumulation in solid tumors but also their ability to interact with immune cells. Silicasomes are highly versatile nanoplatforms composed of a mesoporous silica core whose external surface is coated with a lipid bilayer that allows the co-delivery of therapeutic agents having different chemical natures (small molecules, proteins, enzymes, or oligonucleotides, among others). Herein, cutting-edge advances carried out in the development and application of silicasomes are presented, providing a general description of the performance of these nanotransporters. Additionally, the specific load of chemotherapeutic drugs is explored, followed by a discussion of the immunotherapeutic application of silicasomes and the combination of different therapeutic strategies, including theragnosis, in a single silicasome platform, highlighting the enormous potential of these nanosystems.Keywords
Funding Information
- UE (PID2022-141917OB-I00)
This publication has 113 references indexed in Scilit:
- Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral ImmunotherapyAdvanced Materials Interfaces, 2024
- In Situ Cocktail Nanovaccine for Cancer ImmunotherapyAdvanced Science, 2023
- Mesoporous silica/organosilica nanoparticles for cancer immunotherapyExploration, 2023
- Multifunctional Nanoassemblies for Cytotoxic Drug and Therapeutic Enzymes Delivery in Neuroblastoma TherapyAdvanced Materials Interfaces, 2022
- Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1Advanced Science, 2021
- Cell‐Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen‐Presenting Cells for T Cell ActivationAdvanced Healthcare Materials, 2018
- Molecular Scaffolds as Double‐Targeting Agents For the Diagnosis and Treatment of NeuroblastomaAngewandte Chemie International Edition, 2018
- High‐Drug‐Loading Mesoporous Silica Nanorods with Reduced Toxicity for Precise Cancer Therapy against Nasopharyngeal CarcinomaAdvanced Functional Materials, 2017
- Phospholipid Capped Mesoporous Nanoparticles for Targeted High Intensity Focused Ultrasound AblationAdvanced Healthcare Materials, 2017
- Stable Encapsulation of Air in Mesoporous Silica Nanoparticles: Fluorocarbon‐Free Nanoscale Ultrasound Contrast AgentsAdvanced Healthcare Materials, 2016